B. Riley Securities Serves as Financial Advisor and Lead Placement Agent in $46.9MM Financing
B. Riley Securities led a $46.9 million financing for Radiopharm Theranostics, an ASX-listed clinical stage biotechnology company. The financing consisted of a $4.99 million strategic investment and a $41.9 million institutional placement.
July 3, 2024
B. Riley Securities | financing | Institutional Placement | Lantheus | Patrice McNicoll | Radiopharm Theranostics | Strategic Investment
Brianna Wilson